[{"Assets_0_Q3_USD":"436388000.0","CIK":"1595893","CommonStockSharesConverted_0_Q3_shares":"35839196.0","CommonStockSharesOutstanding_0_Q3_shares":"35839196.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.63","EarningsPerShareBasic_3_Q3_USD":"-2.54","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1579986704.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-43685000.0","NetIncomeLoss_1_Q3_USD":"-20483000.0","NetIncomeLoss_3_Q3_USD":"-51172000.0","OfficialName":"Turning Point Therapeutics Inc. Common Stock","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"420524000.0","Ticker":"TPTX","filed":"20191104","footnote":null,"form":"10-Q","fp":"Q3","fy":"2019.0","name":"TURNING POINT THERAPEUTICS, INC.","period":"20190930","qtrs":"0","uom":"USD"}]